Servicios Personalizados
Revista
Articulo
Inglés (pdf)
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Portuguese Journal of Dermatology and Venereology
versión impresa ISSN 2795-501Xversión On-line ISSN 2795-5001
Resumen
SOARES-CARDOSO, Sandra et al. Stevens-Johnson syndrome/toxic epidermal necrolysis overlap triggered by ethosuximide: a rare pediatric report. Port J Dermatol Venereol. [online]. 2023, vol.81, n.2, pp.124-128. Epub 27-Feb-2023. ISSN 2795-501X. https://doi.org/10.24875/pjdv.22000041.
Introduction:
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe and life-threatening mucocutaneous conditions characterized by fever and necrosis of the epidermis. Up to 90% of cases are drug-induced. Antiseizure drugs (ASD) are known to cause SJS, but only a very few ethosuximide-induced SJS cases have been reported in the literature.
Case presentation:
We report a case of ethosuximide-induced SJS/TEN overlap in a 4-year-old boy, confirmed by patch tests, with improvement with intravenous immunoglobulin (IVIG) and systemic corticosteroid therapy cycle.
Conclusion:
This case highlights the need to expand knowledge about the optimal treatment strategy for these rare conditions, in addition to supportive treatment.
Palabras clave : Antiepileptic drug; Ethosuximide; Stevens-Johnson syndrome; Toxic epidermal necrolysis.
